nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP2A—Epirubicin—uterine cancer	0.272	0.433	CbGbCtD
Lucanthone—TOP2A—Etoposide—uterine cancer	0.212	0.337	CbGbCtD
Lucanthone—TOP2A—Doxorubicin—uterine cancer	0.144	0.23	CbGbCtD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH3—uterine cancer	0.0123	0.0502	CbGpPWpGaD
Lucanthone—APEX1—MMR—MSH3—uterine cancer	0.0117	0.0476	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PMS2—uterine cancer	0.00892	0.0364	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PMS2—uterine cancer	0.00892	0.0364	CbGpPWpGaD
Lucanthone—APEX1—Processive synthesis on the C-strand of the telomere—POLD1—uterine cancer	0.00873	0.0357	CbGpPWpGaD
Lucanthone—APEX1—MMR—PMS2—uterine cancer	0.00847	0.0346	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH6—uterine cancer	0.00739	0.0302	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—POLD1—uterine cancer	0.0073	0.0298	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—POLD1—uterine cancer	0.0073	0.0298	CbGpPWpGaD
Lucanthone—APEX1—myometrium—uterine cancer	0.0073	0.0607	CbGeAlD
Lucanthone—APEX1—MMR—MSH6—uterine cancer	0.00702	0.0287	CbGpPWpGaD
Lucanthone—APEX1—Processive synthesis on the lagging strand—POLD1—uterine cancer	0.00693	0.0283	CbGpPWpGaD
Lucanthone—APEX1—MMR—POLD1—uterine cancer	0.00693	0.0283	CbGpPWpGaD
Lucanthone—APEX1—Gap-filling DNA repair synthesis and ligation in GG-NER—POLD1—uterine cancer	0.0066	0.027	CbGpPWpGaD
Lucanthone—APEX1—Removal of DNA patch containing abasic residue—POLD1—uterine cancer	0.0066	0.027	CbGpPWpGaD
Lucanthone—APEX1—Base Excision Repair—POLD1—uterine cancer	0.00604	0.0247	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH2—uterine cancer	0.00599	0.0245	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH2—uterine cancer	0.00599	0.0245	CbGpPWpGaD
Lucanthone—APEX1—epithelium—uterine cancer	0.00573	0.0477	CbGeAlD
Lucanthone—APEX1—MMR—MSH2—uterine cancer	0.00569	0.0233	CbGpPWpGaD
Lucanthone—APEX1—uterine cervix—uterine cancer	0.00568	0.0473	CbGeAlD
Lucanthone—APEX1—Lagging Strand Synthesis—POLD1—uterine cancer	0.00558	0.0228	CbGpPWpGaD
Lucanthone—APEX1—smooth muscle tissue—uterine cancer	0.00552	0.0459	CbGeAlD
Lucanthone—APEX1—decidua—uterine cancer	0.00541	0.045	CbGeAlD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MLH1—uterine cancer	0.0054	0.0221	CbGpPWpGaD
Lucanthone—APEX1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MLH1—uterine cancer	0.0054	0.0221	CbGpPWpGaD
Lucanthone—APEX1—renal system—uterine cancer	0.00531	0.0442	CbGeAlD
Lucanthone—APEX1—Telomere C-strand (Lagging Strand) Synthesis—POLD1—uterine cancer	0.00519	0.0212	CbGpPWpGaD
Lucanthone—APEX1—endometrium—uterine cancer	0.00514	0.0428	CbGeAlD
Lucanthone—APEX1—MMR—MLH1—uterine cancer	0.00513	0.021	CbGpPWpGaD
Lucanthone—TOP1—myometrium—uterine cancer	0.00511	0.0425	CbGeAlD
Lucanthone—APEX1—mammalian vulva—uterine cancer	0.00497	0.0414	CbGeAlD
Lucanthone—APEX1—uterus—uterine cancer	0.00473	0.0394	CbGeAlD
Lucanthone—APEX1—Extension of Telomeres—POLD1—uterine cancer	0.00431	0.0176	CbGpPWpGaD
Lucanthone—APEX1—female reproductive system—uterine cancer	0.00426	0.0354	CbGeAlD
Lucanthone—APEX1—DNA strand elongation—POLD1—uterine cancer	0.00398	0.0163	CbGpPWpGaD
Lucanthone—TOP1—uterine cervix—uterine cancer	0.00397	0.0331	CbGeAlD
Lucanthone—APEX1—female gonad—uterine cancer	0.00387	0.0322	CbGeAlD
Lucanthone—TOP1—smooth muscle tissue—uterine cancer	0.00386	0.0321	CbGeAlD
Lucanthone—APEX1—vagina—uterine cancer	0.00385	0.032	CbGeAlD
Lucanthone—APEX1—Global Genomic NER (GG-NER)—POLD1—uterine cancer	0.00379	0.0155	CbGpPWpGaD
Lucanthone—TOP1—decidua—uterine cancer	0.00379	0.0315	CbGeAlD
Lucanthone—TOP2A—myometrium—uterine cancer	0.00363	0.0303	CbGeAlD
Lucanthone—TOP1—endometrium—uterine cancer	0.00359	0.0299	CbGeAlD
Lucanthone—TOP1—mammalian vulva—uterine cancer	0.00348	0.0289	CbGeAlD
Lucanthone—TOP1—uterus—uterine cancer	0.00331	0.0276	CbGeAlD
Lucanthone—APEX1—Transcription-coupled NER (TC-NER)—POLD1—uterine cancer	0.00303	0.0124	CbGpPWpGaD
Lucanthone—TOP2A—uterine cervix—uterine cancer	0.00283	0.0235	CbGeAlD
Lucanthone—APEX1—Nucleotide Excision Repair—POLD1—uterine cancer	0.00279	0.0114	CbGpPWpGaD
Lucanthone—TOP1—female gonad—uterine cancer	0.00271	0.0226	CbGeAlD
Lucanthone—TOP2A—decidua—uterine cancer	0.00269	0.0224	CbGeAlD
Lucanthone—TOP1—vagina—uterine cancer	0.00269	0.0224	CbGeAlD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00262	0.0107	CbGpPWpGaD
Lucanthone—TOP2A—endometrium—uterine cancer	0.00256	0.0213	CbGeAlD
Lucanthone—APEX1—lymph node—uterine cancer	0.00249	0.0207	CbGeAlD
Lucanthone—TOP2A—mammalian vulva—uterine cancer	0.00247	0.0206	CbGeAlD
Lucanthone—APEX1—DNA Repair—MSH3—uterine cancer	0.00244	0.00997	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNFSF10—uterine cancer	0.00239	0.00978	CbGpPWpGaD
Lucanthone—TOP2A—uterus—uterine cancer	0.00236	0.0196	CbGeAlD
Lucanthone—APEX1—Telomere Maintenance—POLD1—uterine cancer	0.00195	0.00798	CbGpPWpGaD
Lucanthone—TOP2A—female gonad—uterine cancer	0.00193	0.016	CbGeAlD
Lucanthone—TOP2A—vagina—uterine cancer	0.00192	0.016	CbGeAlD
Lucanthone—APEX1—DNA Repair—PMS2—uterine cancer	0.00177	0.00724	CbGpPWpGaD
Lucanthone—TOP1—lymph node—uterine cancer	0.00174	0.0145	CbGeAlD
Lucanthone—TOP1—Circadian rythm related genes—STAR—uterine cancer	0.00173	0.00706	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—POLD1—uterine cancer	0.00165	0.00675	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—POLD1—uterine cancer	0.00163	0.00664	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—POLD1—uterine cancer	0.00155	0.00634	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—MSH6—uterine cancer	0.00147	0.006	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00147	0.00599	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—POLD1—uterine cancer	0.00145	0.00593	CbGpPWpGaD
Lucanthone—APEX1—Doxorubicin—Epirubicin—uterine cancer	0.00141	0.203	CbGdCrCtD
Lucanthone—TOP1—Circadian rythm related genes—HNF1B—uterine cancer	0.00141	0.00575	CbGpPWpGaD
Lucanthone—APEX1—S Phase—POLD1—uterine cancer	0.00136	0.00554	CbGpPWpGaD
Lucanthone—APEX1—Epirubicin—Doxorubicin—uterine cancer	0.00131	0.188	CbGdCrCtD
Lucanthone—TOP2A—lymph node—uterine cancer	0.00124	0.0103	CbGeAlD
Lucanthone—APEX1—DNA Repair—MSH2—uterine cancer	0.00119	0.00487	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—IGF1R—uterine cancer	0.00109	0.00445	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—MLH1—uterine cancer	0.00107	0.00439	CbGpPWpGaD
Lucanthone—APEX1—Levonorgestrel—Progesterone—uterine cancer	0.001	0.144	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000941	0.00384	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EZH2—uterine cancer	0.000903	0.00369	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000872	0.00356	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—uterine cancer	0.000869	0.00355	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—EP300—uterine cancer	0.000848	0.00347	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.000837	0.00342	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00082	0.00335	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—uterine cancer	0.000803	0.00328	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000792	0.00324	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.00071	0.0029	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MLH3—uterine cancer	0.000694	0.00284	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00069	0.00282	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CDKN1B—uterine cancer	0.000568	0.00232	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000543	0.00222	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—STAR—uterine cancer	0.000539	0.0022	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000529	0.00216	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—uterine cancer	0.000502	0.00205	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—NDC80—uterine cancer	0.000485	0.00198	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.000485	0.00198	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCL2—uterine cancer	0.000462	0.00189	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000462	0.00189	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000458	0.00187	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—CTNNB1—uterine cancer	0.000454	0.00186	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—HNF1B—uterine cancer	0.00044	0.0018	CbGpPWpGaD
Lucanthone—TOP2A—Podofilox—Etoposide—uterine cancer	0.000438	0.063	CbGdCrCtD
Lucanthone—TOP2A—Teniposide—Etoposide—uterine cancer	0.000438	0.063	CbGdCrCtD
Lucanthone—APEX1—Synthesis of DNA—CDKN1B—uterine cancer	0.000421	0.00172	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—POLD1—uterine cancer	0.000413	0.00169	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1B—uterine cancer	0.000395	0.00161	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—uterine cancer	0.000389	0.00159	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000388	0.00159	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000385	0.00157	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—uterine cancer	0.000369	0.00151	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL8—uterine cancer	0.000366	0.00149	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00036	0.00147	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.000357	0.0514	CbGdCrCtD
Lucanthone—APEX1—Spinal Cord Injury—CDKN1B—uterine cancer	0.000357	0.00146	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1B—uterine cancer	0.000345	0.00141	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RRM2—uterine cancer	0.000344	0.00141	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—HRAS—uterine cancer	0.000342	0.0014	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.00034	0.00139	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000331	0.00135	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MLH3—uterine cancer	0.000321	0.00131	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—uterine cancer	0.000318	0.0013	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000316	0.00129	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Progesterone—uterine cancer	0.000311	0.0448	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000309	0.00126	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MLH1—uterine cancer	0.000306	0.00125	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EP300—uterine cancer	0.000303	0.00124	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—uterine cancer	0.000302	0.00124	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—uterine cancer	0.000302	0.00123	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000299	0.00122	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000294	0.0012	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000293	0.0012	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EZH2—uterine cancer	0.000282	0.00115	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—YWHAE—uterine cancer	0.000276	0.00113	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000272	0.00111	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000254	0.00104	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000251	0.00103	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000247	0.00101	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000234	0.000954	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000232	0.000948	CbGpPWpGaD
Lucanthone—TOP2A—Daunorubicin—Epirubicin—uterine cancer	0.000228	0.0329	CbGdCrCtD
Lucanthone—TOP2A—Doxorubicin—Epirubicin—uterine cancer	0.000228	0.0329	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Epirubicin—uterine cancer	0.000228	0.0329	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000226	0.000923	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—NDC80—uterine cancer	0.000224	0.000917	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—uterine cancer	0.000224	0.000917	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000222	0.000906	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—uterine cancer	0.000217	0.000886	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000213	0.000872	CbGpPWpGaD
Lucanthone—TOP2A—Idarubicin—Doxorubicin—uterine cancer	0.000211	0.0304	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	0.000211	0.0304	CbGdCrCtD
Lucanthone—TOP2A—Epirubicin—Doxorubicin—uterine cancer	0.000211	0.0304	CbGdCrCtD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000211	0.000861	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2B—uterine cancer	0.000208	0.000848	CbGpPWpGaD
Lucanthone—TOP2A—Norethindrone—Progesterone—uterine cancer	0.000203	0.0292	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.0002	0.000818	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—POLD1—uterine cancer	0.000191	0.00078	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000191	0.00078	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BIRC5—uterine cancer	0.000179	0.000732	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000178	0.000727	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000167	0.000684	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000165	0.000675	CbGpPWpGaD
Lucanthone—TOP2A—Levonorgestrel—Progesterone—uterine cancer	0.000162	0.0232	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—RRM2—uterine cancer	0.000159	0.00065	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000148	0.000606	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000143	0.000584	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MLH1—uterine cancer	0.000141	0.000577	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000133	0.000542	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000132	0.000541	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—YWHAE—uterine cancer	0.000128	0.000522	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000121	0.000496	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—uterine cancer	0.000119	0.000485	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000118	0.00048	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000112	0.000459	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000107	0.000439	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000106	0.000434	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1B—uterine cancer	0.000105	0.00043	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000103	0.000423	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—EP300—uterine cancer	0.000103	0.000422	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—uterine cancer	9.93e-05	0.000406	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	9.86e-05	0.000403	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2B—uterine cancer	9.6e-05	0.000392	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EP300—uterine cancer	9.47e-05	0.000387	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.34e-05	0.000382	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—BIRC5—uterine cancer	9.26e-05	0.000379	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—EP300—uterine cancer	9.23e-05	0.000377	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BIRC5—uterine cancer	8.28e-05	0.000338	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.94e-05	0.000324	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.3e-05	0.000298	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.06e-05	0.000288	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—uterine cancer	6.78e-05	0.000277	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—uterine cancer	6.61e-05	0.00027	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	6.14e-05	0.000251	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.96e-05	0.000244	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—uterine cancer	5.49e-05	0.000224	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	5.44e-05	0.000222	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1B—uterine cancer	4.86e-05	0.000199	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—EP300—uterine cancer	4.77e-05	0.000195	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—EP300—uterine cancer	4.27e-05	0.000174	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—uterine cancer	3.06e-05	0.000125	CbGpPWpGaD
